Prestige Scoops Up 17 GSK Brands for $660M - Dec. 20, 2011

Having trouble viewing this email? View in Browser.

Tuesday, December 20, 2011  |   |   |   |  Scottish Development International: The home of whisky and the bionic hand, we're the toast of the scientific community Independent analysis shows that Scotland is a high quality, cost effective location to establish your business project. Enter your details to access our FREE Financial Times benchmarking reports on a range of industries that demonstrate Scotland's competitiveness. •   Prestige Brands, Inc. Scoops Up 17 GlaxoSmithKline (GSK) Brands for $660 Million More... •   Accentia Biopharmaceuticals (ABPI) Completes Sale of Analytica Group Subsidiary More... •   Repligen Corporation (RGEN) Completes Acquisition of Novozymes Biopharma Sweden AB More... More Mergers and Acquisitions News •  Provectus Pharmaceuticals Inc. and its Subsidiaries Complete Unregistered Offering of Units to Facilitate Spin-off of Pure-ific Corporation More... More New Company News •   Aviir, Inc. Announces Agreement to Raise Up to $30 Million in Latest Financing Round More... •   Excelimmune, Inc. Raises $12 Million to Advance Infectious Disease Programs and Expand its Human Recombinant Polyclonal Antibody Platform into Additional Therapeutic Areas More... •   Compugen Ltd. (CGEN) to Broaden and Accelerate Monoclonal Antibody Program for Oncology and Immunology; Baize Investments to Provide $8 MillionTowards Expanded Program More... More Finance News Quantifying the Value of Pipeline Pilot, the Accelrys Scientific Enterprise Platform This white paper outlines the methodology, sources of value, and quantifiable results from bringing products to market faster, avoiding unproductive experiments, saving developer time, and more. Request Now! •   Amgen (AMGN) and Watson Pharmaceuticals, Inc. (WPI) Announce $400 Million Collaboration to Develop and Commercialize Oncology Biosimilars More... •   Metamark Genetics, Inc. Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech Inc. for $365 Million More... •   ImmunoGen, Inc. (IMGN) Announces Antibody-Drug Conjugate Collaboration With Eli Lilly and Company (LLY) Worth Up to $200 Million More... •   Antares Pharma, Inc. (AIS) Enters Licensing Agreement with Pfizer Consumer Healthcare (PFE) More... •   ProteoTech Announces Drug Development Collaborative Agreement with GlaxoSmithKline (GSK) for New Parkinson's Therapeutic More... More Alliances News •   China Sky One Medical, Inc.'s Chief Executive Officer to Take Sick Leave More... •   DARA BioSciences, Inc. Reports Appointment of Steve Gorlin as a Director and Designation of David J. Drutz as President and Chief Executive Officer More... •   Coronado Biosciences Appoints Karin Hehenberger, M.D., Ph.D. as Senior Vice President of Scientific Affairs More... •   Amarin Corporation PLC (AMRN) Announces Appointment of Joseph T. Kennedy as General Counsel and Issuance of Inducement Grant Under NASDAQ Rule 5635(c)(4) More... •   Sandford D. Smith Appointed to Aegerion Pharmaceuticals, Inc.' Board of Directors More... More Personnel News •   Bioanalytical Systems, Inc. (BASI) Reports Fiscal 2011 Net Income of $543,000 Versus a Loss of $2.7 Million in Fiscal 2010 as Revenue Increased 15.2% to $33.1 Million More... •   China Cord Blood Corporation Announces Results of 2011 Annual General Meeting More... More Earnings Report News   Exceptional Bioscience Facility Available 25 Crestridge Drive Suwanee, Georgia U.S.A. • 99,822 SF Bioscience Facility • State-of-the-Art Building Systems, Fixtures and Equipment • Constructed in 2000 More Real Estate Listings Hot Company Blue Heron Biotechnology, Inc. 22310 20th Avenue SE, Suite 100 Bothell, Washington 98021 U.S.A. Phone: 425-368-5000 Fax: 425-368-4050 Blue Heron has been a gene synthesis pioneer and leader since its founding in 1999. We provide the broadest range of synthetic DNA sequences and related services to thousands of researchers across multiple industries. More Company Profiles Drug Delivery Partnerships is THE meeting place to discover innovative products, anticipate and take advantage of trends in the partnering landscape and implement best practices to ensure your company stays ahead of the curve. Drug Delivery Partnerships is hailed by all as the world's most authoritative conference on collaboration to drive progress in drug delivery. You will uncover NEW partners, NEW drug delivery technologies, and NEW formulation development strategies to accelerate drugs to market and lengthen lifecycles for long term profitability. For more information, please visit: http://www.iirusa.com/ddp/welcome.xml.   • Biotech Beach (San Diego, California) Sequenom Inc. Business Development Manager Will represent Sequenom products to targeted customers, whose patients may benefit from our superior science. The ideal candidate will plan, develop, and manage long-term relationships with physicians and clinical laboratories to attain or exceed sales targets. • Biotech Bay (Hercules, California) Bio-Rad Laboratories, Inc. Clinical Diagnostics Group Instrument Sales Manager Directs and supervises assigned Account Executives specializing in the IHD product line. Will direct and assist sales staff to achieve unit revenue, profitability and expensive objectives. • Genetown (Cambridge, Massachusetts) Novartis Vaccines & Diagnostics, Inc. Associate Director, Strategic Marketing Drive, integrate, and translate customer insights into development strategy in order to deliver differentiated products with attractive value propositions for our customers. Responsible for the development programs of Novartis Vaccines (Virology and Bacterial). • Pharm Country (Princeton, New Jersey) GE Healthcare Market Access Leader PET Neurology/Oncology The role will have primary responsibilities for product strategies that improve market access with government and commercial payers and providers for the PET Neurology/Oncology Segment. • BioMidwest (Deerfield, Illinois) Astellas Pharma US Associate Director, Reimbursement & Market Access Strategy Will help the Sr. Director lead the strategic and tactical execution over the reimbursement and market access area for the APUS portfolio of marketed products and those in mid-late stage clinical development. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! BioSpace Life Science Career Fairs are the biotech industry's premier career events. Featuring well-respected employers from around the nation, our job fairs attract top candidates in the biotech, pharmaceutical, life science and medical device industries. With such a great number of recruiters and hiring managers from top biotech companies attending our career fairs, there are an abundance of opportunities available for job seekers. Many different disciplines within the industry are represented bringing a diversity of candidates to our job fairs. Companies seeking pharmaceutical sales representatives and marketing jobs regularly attend our job fairs. Engineering and technical jobs can be found, as well as regulatory jobs and positions in QA/QC. Individuals desiring a science job or a research job will find many opportunities at our job fairs. In addition, hiring managers seeking candidates for clinical research jobs also attend our events. More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace, Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace, Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.